With Health Issues Dominating Headlines, 2 ETFs For Illness And Wellness

 | Aug 30, 2021 05:41

"The approved the first vaccine against COVID-19 which was developed jointly by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) and "will now be marketed as Comirnaty."

On the same day, the Dow Jones Health Care Index hit an all-time high and the NASDAQ Biotechnology Index is also hovering close to record highs. Year-to-date (YTD), the indices are up 18.2% and 11.9%, respectively.

The pandemic has meant that biopharma, medical technology, telehealth and insurance companies are high on investors' agenda. We regularly cover exchange-traded funds (ETFs) in the sector that could appeal to a range of buy-and-hold investors.

For instance, we've previously discussed:

  • ALPS Medical Breakthroughs ETF (NYSE:SBIO) - down 8.8% YTD (covered here);
  • ARK Genomic Revolution ETF (NYSE:ARKG) - down 8.9% YTD (covered here);
  • ETFMG Treatments, Testing and Advancements ETF (NYSE:GERM) - up 42.0% YTD (covered here);
  • Health Care Select Sector SPDR® Fund (NYSE:XLV) - up 18.6 % YTD (covered here);
  • iShares Biotechnology ETF (NASDAQ:IBB) - up 13.4% YTD (covered here);
  • iShares US Healthcare Providers ETF (NYSE:IHF) - up 13.6% YTD (covered here);
  • iShares US Medical Devices ETF (NYSE:IHI) - up 18.8% YTD (covered here);
  • SPDR® S&P Biotech ETF (NYSE:XBI) - down 6.2% YTD (covered here).

Today's article introduces two other funds that deserve further due diligence:

1. Fidelity MSCI Health Care Index ETF/h2
  • Current Price: $67.27
  • 52-week range: $50.23 - $67.94
  • Dividend yield: 1.18%
  • Expense ratio: 0.08% per year

The Fidelity® MSCI Health Care Index ETF (NYSE:FHLC) invests in 475 stocks across the broad US health care sector. The fund started trading in October 2013.